Total Payments
$5,931
2024 Payments
$419.48
Companies
40
Transactions
342
Medicare Patients
11,213
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$5,859 (98.8%)
Education$55.07 (0.9%)
Other$17.07 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,859 | 334 | 98.8% |
| Education | $55.07 | 7 | 0.9% |
| Entertainment | $17.07 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,049 | 44 | $0 (2024) |
| GlaxoSmithKline, LLC. | $450.13 | 24 | $0 (2024) |
| Lilly USA, LLC | $424.53 | 39 | $0 (2023) |
| PFIZER INC. | $417.91 | 34 | $0 (2024) |
| ABBVIE INC. | $387.46 | 20 | $0 (2024) |
| Amgen Inc. | $387.08 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $293.75 | 17 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $291.56 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $261.82 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $227.22 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $419.48 | 21 | GlaxoSmithKline, LLC. ($97.38) |
| 2023 | $653.52 | 33 | Novo Nordisk Inc ($187.64) |
| 2022 | $520.85 | 29 | ABBVIE INC. ($235.37) |
| 2021 | $559.05 | 34 | Boehringer Ingelheim Pharmaceuticals, Inc. ($84.44) |
| 2020 | $345.07 | 21 | GlaxoSmithKline, LLC. ($72.54) |
| 2019 | $734.17 | 38 | Novo Nordisk Inc ($118.60) |
| 2018 | $1,118 | 63 | Novo Nordisk Inc ($323.11) |
| 2017 | $1,580 | 103 | Lilly USA, LLC ($279.73) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $28.26 | General |
| 09/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: RESPIRATORY | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Biological | ||||||
| 06/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Bone Health | ||||||
| 05/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.66 | General |
| 03/29/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 03/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Biological | ||||||
| 02/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: VACCINES | ||||||
| 02/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Obesity | ||||||
| 02/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Bone Health | ||||||
| 01/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: VACCINES | ||||||
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,091 | 8,202 | $1.6M | $485,125 |
| 2022 | 25 | 3,015 | 6,692 | $1.3M | $389,157 |
| 2021 | 27 | 2,740 | 5,357 | $1.1M | $320,614 |
| 2020 | 18 | 2,367 | 6,268 | $1.1M | $346,627 |
Total Patients
11,213
Total Services
26,519
Medicare Billing
$1.5M
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 4 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2021 | 16 | 17 | $612.00 | $195.30 | 31.9% |
| 69209 | Removal of impacted ear wax by washing | Office | 2021 | 15 | 15 | $540.00 | $163.24 | 30.2% |
| G0405 | Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination | Office | 2021 | 22 | 22 | $462.00 | $131.60 | 28.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 26 | 98 | $1,960 | $99.19 | 5.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 16 | 22 | $220.00 | $37.06 | 16.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 23 | 69 | $1,725 | $27.90 | 1.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 696 | 1,855 | $483,011 | $133,148 | 27.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2020 | 190 | 1,347 | $210,132 | $64,020 | 30.5% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2020 | 179 | 1,413 | $178,038 | $56,460 | 31.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 284 | 392 | $39,592 | $30,314 | 76.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 329 | 498 | $90,108 | $24,229 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 99 | 99 | $28,908 | $11,276 | 39.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 111 | 111 | $43,048 | $10,586 | 24.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 110 | 130 | $8,970 | $6,989 | 77.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 11 | 11 | $4,565 | $1,803 | 39.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 84 | 84 | $3,780 | $1,494 | 39.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 44 | 45 | $4,974 | $1,432 | 28.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2020 | 79 | 84 | $3,947 | $1,198 | 30.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $4,970 | $1,127 | 22.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 32 | 64 | $3,618 | $1,085 | 30.0% |
| 93922 | Ultrasound study of arteries of both arms and legs | Office | 2020 | 12 | 13 | $2,782 | $685.35 | 24.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 37 | 38 | $1,900 | $435.87 | 22.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 28 | 29 | $1,265 | $304.70 | 24.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 23 | 36 | $720.00 | $40.29 | 5.6% |
About Dr. Jerrelle Copeland, M.D
Dr. Jerrelle Copeland, M.D is a Internal Medicine healthcare provider based in Gold Canyon, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790784643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerrelle Copeland, M.D has received a total of $5,931 in payments from pharmaceutical and medical device companies, with $419.48 received in 2024. These payments were reported across 342 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,859).
As a Medicare-enrolled provider, Copeland has provided services to 11,213 Medicare beneficiaries, totaling 26,519 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Gold Canyon, AZ
- Active Since 07/21/2005
- Last Updated 02/02/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790784643
Products in Payments
- TRELEGY ELLIPTA (Drug) $321.10
- XARELTO (Drug) $227.22
- TRULICITY (Drug) $220.20
- EVENITY (Biological) $211.68
- Victoza (Drug) $206.72
- FARXIGA (Drug) $204.69
- Myrbetriq (Drug) $191.89
- ENTRESTO (Drug) $178.60
- UBRELVY (Drug) $173.10
- JARDIANCE (Drug) $162.25
- Vascepa (Drug) $160.54
- Tresiba (Drug) $152.47
- CHANTIX (Drug) $141.74
- Rybelsus (Drug) $120.10
- TRADJENTA (Drug) $118.83
- Prolia (Biological) $116.49
- Ozempic (Drug) $115.17
- Trintellix (Drug) $114.48
- XIFAXAN (Drug) $107.14
- LYRICA (Drug) $106.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.